Skip to main content
Displaying 1 - 12 of 85
Display:
12
24
48
Viral Hepatitis
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session)
Webcasts
View
Viral Hepatitis
Welcome and Introduction
Webcasts
View
Viral Hepatitis
AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! (Complete Session)
Webcasts
View
Viral Hepatitis
Treating Early Infections – What’s the Problem?
Webcasts
View
Viral Hepatitis
DAAre to Treat When There’s Polypharmacy
Webcasts
View
Viral Hepatitis
What if Patients Have Advanced Liver Disease?
Webcasts
View
Viral Hepatitis
Close
Webcasts
View
Immune-Mediated and Cholestatic Diseases
The evolving goals of PBC treatment
Webcasts
View
Immune-Mediated and Cholestatic Diseases
AdvanzPharma: Shifting Paradigms in PBC Management (Complete Session)
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy